State of Tennessee, Treasury Department »

Catalyst Pharmaceutical Partners shares owned by State of Tennessee, Treasury Department

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by State of Tennessee, Treasury Department from 13F filings

Historical chart of State of Tennessee, Treasury Department investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by State of Tennessee, Treasury Department consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by State of Tennessee, Treasury Department

Quarter filed Position value Share count Share price at filing
2024-03-31 $764k 48k 15.94
2023-09-30 $652k 56k 11.69
2023-06-30 $777k 58k 13.44
2023-03-31 $939k 57k 16.58
2022-12-31 $1.0M 56k 18.61
2022-09-30 $681k 53k 12.81

More positions owned by State of Tennessee, Treasury Department

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corporation Common Stock (NVDA)
Ishares Inc Msci Taiwan Etf Exchange Traded Product (EWT)
Amazon Common Stock (AMZN)
Vanguard Index Fds Total Stk Mkt Exchange Traded Product (VTI)
Ishares Inc Msci Sth Kor Etf Exchange Traded Product (EWY)
Ishares Tr Msci India Etf Exchange Traded Product (INDA)
Meta Platforms Inc Cl A Common Stock (META)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)
Vanguard Scottsdale Fds Int-term Corp Exchange Traded Product (VCIT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt Exchange Traded Product (VEA)
Vanguard Scottsdale Fds Lg-term Cor Bd Exchange Traded Product (VCLT)

View all positions for State of Tennessee, Treasury Department

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Henderson Group
Geode Capital Management
Royce & Associates
Morgan Stanley
Marshall Wace
Robeco Investment Management
Northern Trust
Jacobs Levy Equity Management
T. Rowe Price Associates
Citadel Advisors
Voloridge Investment Management

View all funds holding Catalyst Pharmaceutical Partners